Condition: Extubation · Sponsor: Wake Forest University Health Sciences
Because Propofol is the primary "anesthetic agent," and inhalational agents remain in trace quantities at the end of the procedure Sevoflurane initiated intravenous anesthesia (SIIVA) or not present at all Total intravenous anesthesia (TIVA) it is likely that different criteria may be predictive of extubation success in these patients compared to inhalational anesthesia.
This description comes directly from the study's public registry record.
Wes Templeton, MD · 336-716-4498 · ttemplet@wakehealth.edu
Lynne Harris, BSN · 336-716-8791 · lcharris@wakehealth.edu
Always discuss trial participation with your own doctor first.
| Atrium Health Wake Forest Baptist | Winston-Salem, North Carolina, United States | Recruiting |
| Perth Children's Hospital | Perth, Australia | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05837936